[go: up one dir, main page]

DE69637021D1 - Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen - Google Patents

Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen

Info

Publication number
DE69637021D1
DE69637021D1 DE69637021T DE69637021T DE69637021D1 DE 69637021 D1 DE69637021 D1 DE 69637021D1 DE 69637021 T DE69637021 T DE 69637021T DE 69637021 T DE69637021 T DE 69637021T DE 69637021 D1 DE69637021 D1 DE 69637021D1
Authority
DE
Germany
Prior art keywords
progression
neuropathic pain
analgesia
inhibition
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637021T
Other languages
English (en)
Other versions
DE69637021T2 (de
Inventor
Ramasharma Kristipati
Peter Isadore Adriaenssens
Stephen Scott Bowersox
Theresa Gadbois
Robert R Luther
Gary Arthur Amstutz
Mark Raymond Pettus
Kishochandra Gohil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/496,847 external-priority patent/US5795864A/en
Priority claimed from US08/613,400 external-priority patent/US6054429A/en
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Application granted granted Critical
Publication of DE69637021D1 publication Critical patent/DE69637021D1/de
Publication of DE69637021T2 publication Critical patent/DE69637021T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Control Of El Displays (AREA)
  • Saccharide Compounds (AREA)
DE69637021T 1995-06-27 1996-06-26 Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen Expired - Lifetime DE69637021T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/496,847 US5795864A (en) 1995-06-27 1995-06-27 Stable omega conopetide formulations
US496847 1995-06-27
US08/613,400 US6054429A (en) 1996-03-08 1996-03-08 Epidural method of producing analgesia
US613400P 1996-03-08

Publications (2)

Publication Number Publication Date
DE69637021D1 true DE69637021D1 (de) 2007-05-24
DE69637021T2 DE69637021T2 (de) 2008-01-10

Family

ID=27052304

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69637021T Expired - Lifetime DE69637021T2 (de) 1995-06-27 1996-06-26 Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen
DE1996627153 Active DE122005000043I2 (de) 1995-06-27 1996-06-26 Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der progression neuropathischer Schmerzerkrankungen
DE69627153T Expired - Lifetime DE69627153T2 (de) 1995-06-27 1996-06-26 Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE1996627153 Active DE122005000043I2 (de) 1995-06-27 1996-06-26 Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der progression neuropathischer Schmerzerkrankungen
DE69627153T Expired - Lifetime DE69627153T2 (de) 1995-06-27 1996-06-26 Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen

Country Status (14)

Country Link
EP (2) EP0835126B1 (de)
JP (1) JP2838073B2 (de)
AT (2) ATE235914T1 (de)
AU (1) AU695166B2 (de)
CA (1) CA2224795C (de)
DE (3) DE69637021T2 (de)
DK (2) DK0835126T3 (de)
ES (2) ES2194998T3 (de)
FR (1) FR05C0027I2 (de)
HK (1) HK1058146A1 (de)
LU (1) LU91181I2 (de)
NL (1) NL300201I2 (de)
PT (2) PT835126E (de)
WO (1) WO1997001351A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
AU6109698A (en) * 1998-02-20 1999-09-06 Zeneca Limited Analgesic peptides from venom of (grammostola spatulata) and use thereof
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
EP2386566A3 (de) 2002-12-02 2012-02-15 Xenome Ltd Chi-Conotoxin-Peptide (II)
DK1572725T3 (da) 2002-12-02 2012-06-18 Xenome Ltd Chi-conotoksinpeptider med en N-terminal pyroglutaminsyre
PT1911763E (pt) 2003-01-28 2010-11-18 Ironwood Pharmaceuticals Inc Composições para o tratamento de desordens gastrointestinais
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2930900C (en) 2003-10-02 2018-10-16 Jazz Pharmaceuticals International Limited Combinations of ziconotide and opioids for reducing pain
GB0410215D0 (en) * 2004-05-07 2004-06-09 Lescroart Pol Nerve damage
US8188048B2 (en) 2006-06-23 2012-05-29 Xenome Limited Combination therapy
EP2077854B1 (de) * 2006-11-04 2013-01-23 Anygen Co., Ltd. Omega-conotoxine
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20110129508A1 (en) * 2008-05-06 2011-06-02 Relevare Aust. Pty Ltd Methods and compositions for the management of pain using omega-conotoxins
EP3239170B1 (de) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
CA2745694C (en) 2008-12-03 2018-03-27 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
BRPI0923861B8 (pt) 2008-12-31 2021-05-25 Ardelyx Inc compostos e composições farmacêuticas para inibir o antiporte nhe-mediado no tratamento de distúrbios associados com a retenção de fluido ou com a sobrecarga de sal e distúrbios do trato gastrointestinal
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
RU2015107019A (ru) 2012-08-21 2016-10-10 Эрделикс Инк. Соединения и способы для ингибирования nhe-опосредованного антипорта в лечении расстройств, ассоциированных с задержкой жидкости или солевой перегрузкой и заболеваний желудочно-кишечного тракта
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
SMT201900386T1 (it) 2013-04-12 2019-09-09 Ardelyx Inc Composti nhe3-leganti e metodi per l'inibizione del trasporto di fosfato
ES2981866T3 (es) 2013-06-05 2024-10-10 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclasa C, método de elaboración y uso de los mismos
MX2019008171A (es) 2017-01-09 2020-02-05 Ardelyx Inc Inhibidores del antiporte mediado por nhe.
EP3565808A1 (de) 2017-01-09 2019-11-13 Ardelyx, Inc. Verbindungen zur behandlung erkrankungen des magen-darm-traktes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3926287A1 (de) * 1989-08-09 1991-02-21 Bernhard Clasbrummel Medizinische anwendung von omega-conotoxin gvia oder omega-conotoxin gvia-analoga zur sympathikolyse
US5051403A (en) * 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage
AU3074592A (en) * 1991-11-12 1993-06-15 Neurex Corporation Compositions for delayed treatment of ischemia-related neuronal damage
CA2151741C (en) * 1991-12-30 2001-12-11 Alan Justice Methods of producing analgesia and enhancing opiate analgesia
JPH06247879A (ja) * 1993-02-17 1994-09-06 Bristol Myers Squibb Co デオキシチミジンヌクレオシドを含有する注射用製剤の安定化方法およびその方法によって得られる安定化注射用製剤

Also Published As

Publication number Publication date
NL300201I2 (nl) 2006-02-01
ATE235914T1 (de) 2003-04-15
JP2838073B2 (ja) 1998-12-16
EP1336409A1 (de) 2003-08-20
ES2283671T3 (es) 2007-11-01
HK1058146A1 (en) 2004-05-07
EP0835126B1 (de) 2003-04-02
LU91181I2 (fr) 2005-09-06
EP0835126A1 (de) 1998-04-15
NL300201I1 (nl) 2005-09-01
DK0835126T3 (da) 2003-07-14
PT1336409E (pt) 2007-06-29
DE69627153T2 (de) 2003-12-04
JPH09104634A (ja) 1997-04-22
DE122005000043I2 (de) 2006-08-03
CA2224795C (en) 2001-04-03
PT835126E (pt) 2003-07-31
WO1997001351A1 (en) 1997-01-16
FR05C0027I1 (de) 2005-08-12
DE69637021T2 (de) 2008-01-10
DE122005000043I1 (de) 2006-06-29
CA2224795A1 (en) 1997-01-16
FR05C0027I2 (de) 2006-12-29
DE69627153D1 (de) 2003-05-08
ATE359086T1 (de) 2007-05-15
AU6400296A (en) 1997-01-30
EP1336409B1 (de) 2007-04-11
ES2194998T3 (es) 2003-12-01
DK1336409T3 (da) 2007-08-13
AU695166B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
DE69637021D1 (de) Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen
HU9701059D0 (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
DE69601041D1 (de) Vorrichtung zur Gewinnung von Sauerstoff
DE69309763D1 (de) Vorrichtung zur Herstellung von Rohren
DE59208963D1 (de) Hochwärmebeständige Positivresists und Verfahren zur Herstellung hochwärmebeständiger Reliefstrukturen
ATE330554T1 (de) Enossales einzelzahnimplantat
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
DE69429023D1 (de) Vorrichtung zur Herstellung von Stempeln
DE59309089D1 (de) Lichtempfindliches Gemisch zur Herstellung von Relief- und Druckformen
IL142803A0 (en) Pharmaceutical compositions containing r-tofisopam
DE59408857D1 (de) Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung
DE69402105D1 (de) Vorrichtung zur Herstellung von Elektreten
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
NO982562D0 (no) Sammensetning for behandling av smerte
FR2760635B1 (fr) Procede de preparation d'une composition cosmetique a base de platre et composition cosmetique ainsi obtenue
ZA947912B (en) Treatment of medical disorders associated with free radical formation
ITRM940806A0 (it) Preparato per il trattamento dell'obesita'
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
ATE198831T1 (de) Verwendung von triazinverbindungen zur herstellkung eines arzneimittels zur behandlung von erinnerungs-und lernstörungen
DE69404370D1 (de) Gelatinase A zur Behandlung von der Alzheimerschen Krankheit
DE69407091D1 (de) Vorrichtung zur Herstellung von Ziegelsteinen
ATA217894A (de) Vorrichtung zur herstellung von brezeln
NO984964L (no) Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition